Balance Sheet Details

6 Months Ended

Dec. 31, 2023

Balance Sheet Related Disclosures [Abstract]

3. Balance Sheet Details

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	December 31, 2023			June 30, 2023
Furniture and equipment	$	1,381		$	1,374
Leasehold improvements		969			969
		2,350			2,343
Less: accumulated depreciation		(1,206	)		(1,034	)
Property and equipment, net	$	1,144		$	1,309

Depreciation expense of property and equipment for the three months ended December 31, 2023 and 2022 were $85,000 and $92,000, respectively. Depreciation expense of property and equipment for the six months ended December 31, 2023 and 2022 are presented in the condensed consolidated statements of cash flows.

Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):



	December 31, 2023		June 30, 2023
Accrued pre-clinical and clinical trial expenses	$	810	$	3,663
Accrued compensation and benefits(1)		2,236		7,189
Accrued legal and professional services		1,541		1,423
Accrued reimbursement to KKC		892		—
Other		166		186
Total accrued liabilities	$	5,645	$	12,461

(1) Includes $0.2 million and $1.0 million of one-time termination employee benefits as of December 31, 2023 and June 30, 2023, respectively, as more fully described in Note 5. One-time Employee Termination Benefits.